Obermatt
See Similar Stocks →

BML

TYO:4694 · JP3799700004
Health Care Providers & ServicesMedium

360

74
EV / EBIT94
Price / Owner Earnings32
Owner Earnings Yield96
Dividend Yield83
Price/Sales72
EV / Gross Profit93
Price/Book71
Return on Capital64
Cash Return on Capital63
Return on Equity60
EBIT Margin64
Gross Profitability43
Cash Conversion58
Accruals45
Owner Earnings Margin67
Sales growth28
Profit Growth59
Long-Term EPS Growth18
Reinvestment26
Price momentum72
Debt load85
Refinancing20
Debt Payback100
Liquidity88
Analyst ratings8
Opinion Changes4
Price Target Upside49
Market mood39
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

BML clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeTSE
Founded1955
Employees1
Websitebml.co.jp
ISINJP3799700004
Last UpdateApr 2, 2026
Index & Theme
HematologyHealth DiagnosticsDiabetesInfectious DiseasesOncologyGeneticsHealth CareMedical

Description

BML, Inc. provides laboratory testing and related services in Japan. Business Segments The company operates through several key segments, each of which plays a vital role in the overall operation and growth of the company. The primary business segm…

Analysis

Bargain bin

BML, Inc. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is fair. The owner-earnings multiple stands at 15.7×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
58
2023202420252026

All-time high

100

Jan 2023

All-time low

58

Jun 2026

Average rank

78

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
72
76
79
77
Price/Earnings
64
54
81
97
Price/Book
71
89
83
77
Dividend Yield
83
65
62
60
Value (overall)
86
85
95
95

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare BML with its peers
H.U. Group Holdings
TYO:4544
83
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
M3
TYO:2413
87
CountryJapan
IndustryHealth Care Technology
SizeLarge
Full Stock Analysis →
Solasto
TYO:6197
59
CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Ebos
NZC:EBO
40
CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Pro Medicus
ASX:PME
67
CountryAustralia
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Sysmex
TYO:6869
77
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →